Evidence map›Paper›PMID 33148265›Full record

ArticleMalaria journal2020

Impact of Plasmodium falciparum gene deletions on malaria rapid diagnostic test performance.

Michelle L Gatton, Alisha Chaudhry, Jeff Glenn, Scott Wilson, Yong Ah, Amy Kong, Rosalynn L Ord, Roxanne R Rees-Channer, Peter Chiodini, Sandra Incardona and 3 more

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 3 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 3 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Remoscope: a label-free imaging cytometer for malaria diagnostics.Transactions of the Royal Society of Tropical Medicine and Hygiene · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Diagnostic accuracy ofExperimental biology and medicine (Maywood, N.J.) · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 4 countries.

Michelle L GattonQueensland University of Technology, Brisbane, QLD, Australia. m.gatton@qut.edu.au.ORCID http://orcid.org/0000-0003-1188-609X
Alisha ChaudhryQueensland University of Technology, Brisbane, QLD, Australia.
Jeff GlennThe CDC Foundation, Atlanta, GA, USA.
Scott WilsonThe CDC Foundation, Atlanta, GA, USA.
Yong AhThe CDC Foundation, Atlanta, GA, USA.
Amy KongCenters for Disease Control and Prevention, Atlanta, USA.
Rosalynn L OrdHospital for Tropical Diseases, London, UK.
Roxanne R Rees-ChannerHospital for Tropical Diseases, London, UK.
Peter ChiodiniHospital for Tropical Diseases, London, UK.
Sandra IncardonaFoundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
Qin ChengAustralian Defence Force Malaria and Infectious Diseases Institute (FORMERLY Australian Army Malaria Institute), Brisbane, QLD, Australia.
Michael AidooCenters for Disease Control and Prevention, Atlanta, USA.
Jane CunninghamWorld Health Organization, Geneva, Switzerland.
CDC Foundation · USCenters for Disease Control and Prevention · USHospital for Tropical Diseases · GBQueensland University of Technology · AUFIND · CHLondon School of Hygiene & Tropical Medicine · GBWorld Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundMalaria rapid diagnostic tests (RDTs) have greatly improved access to diagnosis in endemic countries. Most RDTs detect Plasmodium falciparum histidine-rich protein 2 (HRP2), but their sensitivity is seriously threatened by the emergence of pfhrp2-deleted parasites. RDTs detecting P. falciparum or pan-lactate dehydrogenase (Pf- or pan-LDH) provide alternatives. The objective of this study was to systematically assess the performance of malaria RDTs against well-characterized pfhrp2-deleted P. falciparum parasites.

methodsThirty-two RDTs were tested against 100 wild-type clinical isolates (200 parasites/µL), and 40 samples from 10 culture-adapted and clinical isolates of pfhrp2-deleted parasites. Wild-type and pfhrp2-deleted parasites had comparable Pf-LDH concentrations. Pf-LDH-detecting RDTs were also tested against 18 clinical isolates at higher density (2,000 parasites/µL) lacking both pfhrp2 and pfhrp3.

resultsRDT positivity against pfhrp2-deleted parasites was highest (> 94%) for the two pan-LDH-only RDTs. The positivity rate for the nine Pf-LDH-detecting RDTs varied widely, with similar median positivity between double-deleted (pfhrp2/3 negative; 63.9%) and single-deleted (pfhrp2-negative/pfhrp3-positive; 59.1%) parasites, both lower than against wild-type P. falciparum (93.8%). Median positivity for HRP2-detecting RDTs against 22 single-deleted parasites was 69.9 and 35.2% for HRP2-only and HRP2-combination RDTs, respectively, compared to 96.0 and 92.5% for wild-type parasites. Eight of nine Pf-LDH RDTs detected all clinical, double-deleted samples at 2,000 parasites/µL.

conclusionsThe pan-LDH-only RDTs evaluated performed well. Performance of Pf-LDH-detecting RDTs against wild-type P. falciparum does not necessarily predict performance against pfhrp2-deleted parasites. Furthermore, many, but not all HRP2-based RDTs, detect pfhrp2-negative/pfhrp3-positive samples, with implications for the HRP2-based RDT screening approach for detection and surveillance of HRP2-negative parasites.

Indexed as

Gene DeletionAntigens, ProtozoanDiagnostic Tests, RoutineMalaria, FalciparumPlasmodium falciparumProtozoan ProteinsAntigens, ProtozoanHRP-2 antigen, Plasmodium falciparumHRP3 protein, Plasmodium falciparumProtozoan ProteinsGene deletionHisidine rich protein 2HRP2Rapid diagnostic tests

Identifiers

PMID33148265
PMCPMC7640408
OpenAlexW3095762491

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.